Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Non-Interventional Study Exploring the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With a Chemotherapy Combined With Bevacizumab

NCT02673710 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02673710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02673710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Non-Interventional Study Exploring the Impact of Sarcopenia on the Outcomes of Colorectal Cancer Patients Treated With a Chemotherapy Combined With Bevacizumab
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
March 14, 2016
Completion date
February 4, 2020
Enrollment
200 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic colorectal cancer